Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MSLESatellos Bioscience Inc.

Nasdaq · CIK 0001421642
Filer category<br>Emerging growth company
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts99

Identity from submissions API

NameSatellos Bioscience Inc.
CIK0001421642
TickersMSLE
ExchangesNasdaq
Entity typeother
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationZ4 Canada (Federal Level)
Phone647-660-1780
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • ICO THERAPEUTICS INC (2007-12-17T05:00:00.000Z → 2019-09-10T04:00:00.000Z)
Business address
15 ALLSTATE PARKWAY
SUITE 600
MARKHAM
L3R 5B4
Ontario, Canada
A6
Mailing address
15 ALLSTATE PARKWAY
SUITE 600
MARKHAM
L3R 5B4
Ontario, Canada
A6

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

56 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 6-K FORM 6-K 0001171843-26-007371 001-43107 261543040 34 914857
2026-11-06 6-K FORM 6-K 0001171843-26-007206 001-43107 261529273 34 21656
2026-11-05 6-K FORM 6-K 0001171843-26-007184 001-43107 261527952 34 15101
2026-10-27 6-K FORM 6-K 0001171843-26-006835 001-43107 261487297 34 17326
2026-10-21 6-K FORM 6-K 0001171843-26-006724 001-43107 261474139 34 15239
2026-10-05 6-K FORM 6-K 0001171843-26-006380 001-43107 261438746 34 17292
2026-09-30 6-K FORM 6-K 0001171843-26-006303 001-43107 261425476 34 18541
2026-09-24 6-K FORM 6-K 0001171843-26-006202 001-43107 261402128 34 23353
2026-09-15 6-K FORM 6-K 0001171843-26-006046 001-43107 261379112 34 18393
2026-09-09 6-K FORM 6-K 0001171843-26-005936 001-43107 261366647 34 17900
2026-09-01 6-K FORM 6-K 0001171843-26-005825 001-43107 261348492 34 17240
2026-08-14 6-K FORM 6-K 0001104659-26-097247 001-43107 261282614 34 314982
2026-08-14 SUPPL SUPPL 0001104659-26-097197 333-298223 261282037 NE 1187295
2026-08-13 6-K FORM 6-K 0001171843-26-005503 001-43107 261274739 34 883930
2026-08-11 F-X FORM F-X 0001104659-26-094066 333-298223 261263471 33 20304
2026-08-11 F-10 F-10 0001104659-26-094033 333-298223 261263058 33 1022322 1 1
2026-07-08 6-K FORM 6-K 0001171843-26-004525 001-43107 261160728 34 2240255
2026-06-29 6-K FORM 6-K 0001171843-26-004332 001-43107 261131269 34 17395
2026-06-25 6-K FORM 6-K 0001171843-26-004290 001-43107 261117605 34 16169
2026-06-18 6-K FORM 6-K 0001171843-26-004179 001-43107 261099604 34 28706
2026-06-17 6-K FORM 6-K 0001171843-26-004176 001-43107 261099319 34 29437
2026-05-27 6-K FORM 6-K 0001171843-26-003717 001-43107 261022132 34 10686
2026-05-20 6-K FORM 6-K 0001171843-26-003561 001-43107 261001538 34 2028509
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-057586 005-95673 26986053 34 13212
2026-05-15 6-K FORM 6-K 0001171843-26-003453 001-43107 26982128 34 1136133
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001855820-26-000004 005-95673 26968986 34 16570
2026-04-09 6-K FORM 6-K 0001171843-26-002337 001-43107 26849782 34 10935
2026-03-27 S-8 FORM S-8 0001104659-26-035734 333-294666 26801236 33 2990562 1 1
2026-03-27 40-F 40-F 0001104659-26-035729 001-43107 26801213 34 8729720 1 1
2026-03-27 6-K FORM 6-K 0001171843-26-001965 001-43107 26801005 34 24044
2026-03-10 6-K FORM 6-K 0001171843-26-001445 001-43107 26737117 34 19586
2026-02-24 6-K FORM 6-K 0001104659-26-018818 001-43107 26667508 34 37078
2026-02-19 6-K FORM 6-K 0001104659-26-017379 001-43107 26652489 34 26805
2026-02-18 6-K FORM 6-K 0001104659-26-016955 001-43107 26647156 34 31983
2026-02-17 6-K FORM 6-K 0001104659-26-016282 001-43107 26640214 34 31800
2026-02-12 6-K FORM 6-K 0001104659-26-013851 001-43107 26623396 34 37072
2026-02-10 6-K FORM 6-K 0001104659-26-012339 001-43107 26613452 34 25772
2026-02-10 6-K FORM 6-K 0001104659-26-012228 001-43107 26613059 34 37330
2026-02-06 6-K FORM 6-K 0001104659-26-011529 001-43107 26607834 34 512661
2026-02-06 SUPPL SUPPL 0001104659-26-011276 333-293229 26605414 NE 1120799
2026-02-06 CERT MSLE_8A_Cert_1421642.pdf 0001354457-26-000146 001-43107 26605262 34 124267
2026-02-05 8-A12B 8-A12B 0001104659-26-010969 001-43107 26603578 34 17582
2026-02-05 F-X FORM F-X 0001104659-26-010959 333-293229 26603543 33 22393
2026-02-05 F-10 F-10 0001104659-26-010890 333-293229 26602979 33 7820212 1 1
2025-01-03 D xslFormDX01/primary_doc.xml 06b 0001421642-25-000001 021-534194 25506596 33 19543
2023-05-25 D xslFormDX01/primary_doc.xml 06b 0001421642-23-000001 021-482637 23959856 33 15936
2022-09-27 D xslFormDX01/primary_doc.xml 06b 0001421642-22-000003 021-459948 221268369 33 14254
2019-09-10 D xslFormDX01/primary_doc.xml 06b 0001421642-19-000002 021-348370 191084395 33 9200
2019-03-08 D xslFormDX01/primary_doc.xml 06b 0001421642-19-000001 021-334420 19669212 33 9718
2014-02-05 D xslFormDX01/primary_doc.xml 06b 0001421642-14-000001 021-211358 14576128 33 12392
2013-11-21 D/A xslFormDX01/primary_doc.xml 06b 0001421642-13-000003 021-168712 131234369 33 10933
2011-11-15 D xslFormDX01/primary_doc.xml 06 0001421642-11-000001 021-168712 111206617 33 10478
2009-12-01 D/A xslFormDX01/primary_doc.xml 06 0001421642-09-000004 021-112306 091214237 33 12890
2009-11-06 D xslFormDX01/primary_doc.xml 06 0001421642-09-000003 021-112306 091163676 33 12749
2009-03-12 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-09-011457 021-112306 09036230 34 1619
2007-12-17 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-051963 021-112306 07086013 34 1611

Latest XBRL company facts

One latest value per concept from companyfacts (99 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 15.46M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ffd NetFeeAmt NetFeeAmt USD 28,655.75 2026-08-07 F-10 2026-08-11 0001104659-26-094033
ffd TtlFeeAmt TtlFeeAmt USD 41,430 2026-08-07 F-10 2026-08-11 0001104659-26-094033
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-08-07 F-10 2026-08-11 0001104659-26-094033
ffd TtlOffsetAmt TtlOffsetAmt USD 12,774.25 2026-08-07 F-10 2026-08-11 0001104659-26-094033
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-07 F-10 2026-08-11 0001104659-26-094033
ifrs-full AccountingProfit AccountingProfit USD -24.70M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome USD -1.72M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdditionalPaidinCapital AdditionalPaidinCapital USD 10.17M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 14.60M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForDecreaseIncreaseInPrepaidExpenses AdjustmentsForDecreaseIncreaseInPrepaidExpenses USD -2.04M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables USD 65,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForDepreciationExpense AdjustmentsForDepreciationExpense USD 4,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForFinanceIncome AdjustmentsForFinanceIncome USD 358,000 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives USD -3,000 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss USD 2.90M 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables USD 501,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments USD 3.23M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full AdjustmentsForUnrealisedForeignExchangeLossesGains AdjustmentsForUnrealisedForeignExchangeLossesGains USD -484,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ApplicableTaxRate ApplicableTaxRate pure 0.265 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full Assets Assets USD 31.89M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full BalancesWithBanks BalancesWithBanks USD 4.38M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare USD/shares -1.7 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CashAndCashEquivalents CashAndCashEquivalents USD 9.80M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities USD 2.24M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities USD -9.42M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities USD -23.60M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ComprehensiveIncome ComprehensiveIncome USD -24.86M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ContractualCapitalCommitments ContractualCapitalCommitments USD 23.14M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentAdvancesToSuppliers CurrentAdvancesToSuppliers USD 3.62M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentAssets CurrentAssets USD 31.88M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentDerivativeFinancialAssets CurrentDerivativeFinancialAssets CAD 4,000 2023-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentFinancialLiabilities CurrentFinancialLiabilities USD 2.26M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentInvestments CurrentInvestments USD 17.91M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentLiabilities CurrentLiabilities USD 4.11M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentPrepaidExpenses CurrentPrepaidExpenses USD 187,000 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentPrepayments CurrentPrepayments USD 3.80M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full CurrentTaxLiabilities CurrentTaxLiabilities USD 72,000 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised USD 97.13M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full DescriptionOfExpectedVolatilityShareOptionsGranted DescriptionOfExpectedVolatilityShareOptionsGranted pure 0.84 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full DescriptionOfOptionLifeShareOptionsGranted DescriptionOfOptionLifeShareOptionsGranted Y 10 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full DescriptionOfRiskFreeInterestRateShareOptionsGranted DescriptionOfRiskFreeInterestRateShareOptionsGranted pure 0.031 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full DilutedEarningsLossPerShare DilutedEarningsLossPerShare USD/shares -1.7 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents USD 503,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full Equity Equity USD 27.78M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full EquityAndLiabilities EquityAndLiabilities USD 31.89M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted pure 0 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets USD 3.23M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full FinanceIncome FinanceIncome USD 1.36M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ForeignExchangeGain ForeignExchangeGain USD 398,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense USD 8.03M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill CAD 3.96M 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IncomeTaxExpenseContinuingOperations IncomeTaxExpenseContinuingOperations USD 172,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents USD -30.27M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IncreaseDecreaseThroughExerciseOfOptions IncreaseDecreaseThroughExerciseOfOptions USD 147,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity USD 2.09M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions USD 3.23M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full InterestReceivedClassifiedAsOperatingActivities InterestReceivedClassifiedAsOperatingActivities USD 1.16M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IssuedCapital IssuedCapital USD 85.83M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full IssueOfEquity IssueOfEquity USD 29.98M 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation USD 4.74M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment USD 2.06M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full KeyManagementPersonnelCompensationShorttermEmployeeBenefits KeyManagementPersonnelCompensationShorttermEmployeeBenefits USD 2.68M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full Liabilities Liabilities USD 4.11M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full LossesOnChangeInFairValueOfDerivatives LossesOnChangeInFairValueOfDerivatives CAD 2,000 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full NoncurrentAssets NoncurrentAssets USD 5,000 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions Options 26.44M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement Options 8.88M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full NumberOfShareOptionsExercisedInSharebasedPaymentArrangement NumberOfShareOptionsExercisedInSharebasedPaymentArrangement Options 413,563 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement Options 13.92M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation USD 17,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProceedsFromExerciseOfOptions ProceedsFromExerciseOfOptions USD 147,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants USD 2.09M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares USD 30.06M 2024-01-01 2024-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod USD 13.96M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProfitLoss ProfitLoss USD -24.87M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax USD -24.70M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities USD -26.46M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment USD 5,000 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod USD 23.37M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities USD 6,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense USD 18.43M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full RetainedEarnings RetainedEarnings USD -81.97M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full RiskExposureAssociatedWithInstrumentsSharingCharacteristic RiskExposureAssociatedWithInstrumentsSharingCharacteristic USD 23.61M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ShareIssueRelatedCost ShareIssueRelatedCost USD 3.10M 2024-12-20 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full ShorttermInvestmentsClassifiedAsCashEquivalents ShorttermInvestmentsClassifiedAsCashEquivalents USD 5.42M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full TaxEffectFromChangeInTaxRate TaxEffectFromChangeInTaxRate USD -1.24M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss USD 543,000 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate USD -6.55M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables USD 4.11M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full TradeAndOtherCurrentPayablesToTradeSuppliers TradeAndOtherCurrentPayablesToTradeSuppliers USD 1.77M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised USD 77.91M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WarrantReserve WarrantReserve USD 15.48M 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 CAD/shares 0.81 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 CAD/shares 0.5 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 CAD/shares 0.74 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 CAD/shares 0.73 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageFairValueAtMeasurementDateShareOptionsGranted WeightedAverageFairValueAtMeasurementDateShareOptionsGranted USD 0.44 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729
ifrs-full WeightedAverageShares WeightedAverageShares shares 14.60M 2025-01-01 2025-12-31 2025 FY 40-F 2026-03-27 0001104659-26-035729

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →